Evidence map›Paper›PMID 42730184›Full record

ArticleACS omega2026

Organotin-Catalyzed Synthesis, Characterization, Anticancer and Antioxidant Activities, and Molecular Modeling Studies of Nimesulide Ureas as Potential MetAP (Type II) Inhibitors.

Yağmur Biliz, Özgür Yılmaz, Elif Kuloğlu, İpek Bedir, Egemen Çakırlı, Şevval Arslan, Dilek Telci, Özge Çevik, Kemal Yelekçi, Gani Koza and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yağmur BilizDepartment of Chemical Engineering, Faculty of Engineering and Natural Sciences, Istanbul Health and Technology University, Istanbul 34275, Turkiye.ORCID https://orcid.org/0000-0002-4181-7290
Özgür YılmazTUBITAK Marmara Research Center, Gebze, Kocaeli 41470, Turkiye.
Elif KuloğluTUBITAK Marmara Research Center, Gebze, Kocaeli 41470, Turkiye.
İpek BedirDepartment of Genetics and Bioengineering, Yeditepe University, Istanbul 34755, Turkiye.
Egemen ÇakırlıDepartment of Genetics and Bioengineering, Yeditepe University, Istanbul 34755, Turkiye.
Şevval ArslanTUBITAK Marmara Research Center, Gebze, Kocaeli 41470, Turkiye.
Dilek TelciDepartment of Genetics and Bioengineering, Yeditepe University, Istanbul 34755, Turkiye.ORCID https://orcid.org/0000-0002-2793-6533
Özge ÇevikDepartment of Biochemistry, School of Medicine, Aydın Adnan Menderes University, Aydın 09010, Turkiye.
Kemal YelekçiDepartment of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Kadir Has University, Istanbul 34083, Turkiye.ORCID https://orcid.org/0000-0002-0052-4926
Gani KozaDepartment of Chemistry, Faculty of Art and Science, Bursa Uludağ University, Bursa 16059, Turkiye.
Ş Güniz KüçükgüzelDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Fenerbahçe University, Atasehir, Istanbul 34758, Turkiye.ORCID https://orcid.org/0000-0001-9405-8905

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a new series of nimesulide-derived ureas (

Identifiers

PMID42730184
PMCPMC13564012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.